IL10RA and cholangiocarcinoma: The above data are in agreement with the results obtained by Thepmalee et al., which found that T cells activated by DCs with half-decreased IL-10R expression showed increased cytolytic activity against cholangiocarcinoma cells compared to T cells stimulated by DCs transduced with control shRNA sequence (25).